	Real-World Treatment Practice and Survival Outcomes in Elderly Patients With Nasopharyngeal Carcinoma. Br J Hosp Med (Lond) Lu Z, Guo L, You Z, Yu Y, Wu S, Li Y. PMID: 42528433 [PubMed - indexed for MEDLINE]
	The chain-mediating role of anxiety and depression in the relationship between symptom clusters and perceived cognitive function in nasopharyngeal carcinoma survivors: a cross-sectional study of 556 participants. Support Care Cancer Liu S, He Y, Xiao M, Fan Y, Li J. PMID: 42527676 [PubMed - indexed for MEDLINE]
	An Epstein-Barr Virus Nuclear Antigen 1 (EBNA1) Serology Test Strip for Nasopharyngeal Carcinoma Risk Screening. J Med Virol Warner BE, Patel J, Satterwhite R, Wang R, Adams-Haduch J, Koh WP, Yuan JM, Shair KHY. PMID: 42504130 [PubMed - indexed for MEDLINE]
	Otolaryngologic Symptom Burden, Emotional Distress, and Stigma in Nasopharyngeal Carcinoma Survivors: A Prospective Cohort Study. Psychooncology Shih YL, Lin CY, Chen WC, Luo SD, Wang YM, Li SH, Hwang CF, Hsieh HC, Wu CN. PMID: 42480561 [PubMed - indexed for MEDLINE]
	Pretreatment multiparametric MRI-based habitat radiomics and 2.5D deep learning for predicting early complete response to induction chemoimmunotherapy in locally advanced nasopharyngeal carcinoma. Oral Oncol Zhu B, Wen Z, Chen K, Zhu L, Li L, Long L, Zhu X. PMID: 42435493 [PubMed - indexed for MEDLINE]
	Immune checkpoint inhibitor integration in locoregionally advanced nasopharyngeal carcinoma: a prospective evidence synthesis on efficacy, safety, and therapeutic optimization. Front Immunol Chen P, Jiang Y, Han C, Jian L, Gong Y, Xie H, Zhang Z, Han Y. PMID: 42433378 [PubMed - indexed for MEDLINE]
	Primary nasopharyngeal Kaposi's sarcoma without cutaneous manifestations: a case report. J Med Case Rep Lugina EL, Ernesti ZM, Nundu EL, Mlole AT, Tupa F, StanleyNoah H, Mwita CJ, Mosha IJ, Iddy S, Kahesa CA, Ngalamika O, Wood C, Mwaiselage JD, Lidenge SJ. PMID: 42421086 [PubMed - indexed for MEDLINE]
	Effectiveness and Safety of Anlotinib with or without PD-1 Blockades in Patients with Platinum-Resistant or Immunotherapy-Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma: A Retrospective, Real-World Study. Drug Des Devel Ther Chen K, Li Y, Chen X, Zhu W, Shi Y, Ye X, Jiang C, Li Y, Liu F. PMID: 42415935 [PubMed - indexed for MEDLINE]
	Multimodal PET/CT Image Fusion-Derived Parameters and Biochemical Indices for Prognostic Monitoring in Nasopharyngeal Carcinoma: A Review. Br J Hosp Med (Lond) Hu Q, Kong L, Deng J. PMID: 42411517 [PubMed - indexed for MEDLINE]
	Prevalence and Clinical Findings of Nasopharyngeal Reflux in Patients With Idiopathic Nasal Symptoms: A Preliminary Study. J Otolaryngol Head Neck Surg Lechien JR. PMID: 42394145 [PubMed - indexed for MEDLINE]
	Evaluation of radiotherapy dose and survival outcomes for teenagers, and young adults with nasopharyngeal carcinoma in UK & Ireland. Oral Oncol Gaffney J, France A, Rieu R, Wang Y, Glynn AM, Brown K, Rooney C, Thomas A, Swan A, Kapacee Z, Herbert L, Horan G, Garcez K, Price J, Lee L, Hughes C, Thorp N, Whitfield G, Brennan B, Dyker K, Noble D, Benghiat H, Dixon L, Houghton F, Mandeville HC, Brennan SM, Gains JE, Lim PS, Smith E, Thomson D, McPartlin A, Pan S. PMID: 42391825 [PubMed - indexed for MEDLINE]
	Epstein-Barr virus-driven immunosuppression in nasopharyngeal carcinoma: a comprehensive review of viral mechanisms, spatial tumor ecosystems, and precision therapeutics. Front Immunol Qu H, Zhang P, Tang Y, Chang T. PMID: 42389513 [PubMed - indexed for MEDLINE]
	Synthetic CT-enabled weekly adaptive radiotherapy for nasopharyngeal carcinoma: Optimizing plan adaptation triggers through volumetric-dosimetric monitoring. J Appl Clin Med Phys Cao Z, Wu C, Han L, Duan T, Zhang F, Zhang L, Wang B, Lei W, Ni X. PMID: 42385153 [PubMed - indexed for MEDLINE]
	Cross-Platform Gene Signature to Predict Survival Outcomes for Nasopharyngeal Carcinoma. JCO Precis Oncol Li H, Jing Q, Chow JCH, Cheuk W, Chan KSK, Hao S, Islam KA, Dai W, Lam KO, Lee VHF, Ng WT, Ngan RKC, Lee AWM, Wong JWH, Chiang CL. PMID: 42385107 [PubMed - indexed for MEDLINE]
	Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study. Nat Cancer Tao YL, Wu DH, Zhou Q, Yang KY, Jin F, Zhu XD, Shi M, Hu GQ, Sun Y, Wu HF, Wu H, Lin Q, Wang H, Tian Y, Zhang N, Wang XC, Shen LF, Liu ZZ, Huang J, Luo XL, Li L, Zang J, Mei Q, Zheng BM, Yue D, Xu J, Wu SG, Chen L, Li WF, Zhou GQ, Sun R, Guo R, Zhang Y, Xu C, Lv JW, Guo Y, Feng HX, Tang LL, Xie FY, Liu X, Sun Y, Ma J, Mao YP, Chen YP. PMID: 42380630 [PubMed - indexed for MEDLINE]
	Mechanisms and clinical challenges of ICB-mediated remodeling of the tumor microenvironment in nasopharyngeal carcinoma. Oral Oncol Ou C, Qi L, Lai H, Ye J, Tian X, Li Z. PMID: 42372494 [PubMed - indexed for MEDLINE]
	Deep learning-based reconstruction for 5.0T magnetic resonance imaging (MRI) in nasopharyngeal carcinoma: comparison of image quality and diagnostic efficacy. Clin Radiol Zhou P, Liu H, Xu G, Lin H, Yu Z, He H, Xie C. PMID: 42361579 [PubMed - indexed for MEDLINE]
	SAM-guided structural consistency constraints for unsupervised MR-to-CT synthesis. Appl Radiat Isot Zhang J, Zhang Y, Zhang X, Li C, Ling C, Yang W. PMID: 42361423 [PubMed - indexed for MEDLINE]
	Clinical Analysis of Rotational-Translational Error Coupling in 3DoF Versus 6DoF CBCT Couch Corrections:A Cross-Sectional Study. Technol Cancer Res Treat Yi L, Li K, Zhong R, Yue H, Lu Z. PMID: 42305096 [PubMed - indexed for MEDLINE]
	Illustrating repopulation-corrected dose metrics across heterogeneous radiotherapy schedules in nasopharyngeal carcinoma. Phys Med Oebel L, Grad C, Wollschläger D, Pollul G, Kyryschuk E, Schmidberger H. PMID: 42302591 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 9196

Page 1 of 460



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy